Related Experiment Videos
Prolonged administration of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) after
T De Witte1, G Vreugdenhil, A Schattenberg
1Department of Internal Medicine, University Hospital St Radboud, Nijmegen, The Netherlands.
Transplantation Proceedings
|August 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Rechallenge of ipilimumab and nivolumab in advanced melanoma patients after previous ipilimumab-based therapy.
British journal of cancer·2025
Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: a propensity score matched survival analysis.
British journal of cancer·2025
Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry.
European journal of cancer (Oxford, England : 1990)·2024
Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma.
Immuno-oncology technology·2024
The Role of Varying Cardiac Troponin Levels in Long-Term Mortality in Liver Transplant Patients.
Transplantation proceedings·2026
Evaluation of Scoring Systems in Kidney Transplantation: A Single Center Experience.
Transplantation proceedings·2026
Fat Embolism Syndrome as Cause of Death in a Multiorgan Donor With Successful Utilization of Thoracic and Abdominal Organs.
Transplantation proceedings·2026
Mechanical circulatory support devices in heart failure: a narrative review of current evidence, clinical applications, complications, and future directions.
Frontiers in cardiovascular medicine·2026
Pharmacotherapy for MASLD/MASH: approved therapies, drug repurposing, and emerging mechanism-based candidates.
Expert opinion on pharmacotherapy·2026
Effectiveness and safety of three years of bulevirtide monotherapy in patients with HDV-related compensated cirrhosis: the Italian compassionate use program.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026
Long-term outcomes of alemtuzumab in relapsing-remitting multiple sclerosis: a real-world cohort with particular focus on treatment sequencing after natalizumab.
Journal of the neurological sciences·2026